We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-10 of 499

SaMD Series: What Should Life Sciences Companies Know?
  • Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • USA
  • August 14 2018

Software as a Medical Device - also referred to as SaMD - is one of the fastest growing innovations in the medical device industry. As with any

Current Legislation No. 23 (2018)
  • Gómez-Acebo & Pombo Abogados
  • Spain, European Union
  • April 17 2018

Royal Decree 62018, of 12 January, creating the Interdepartmental Committee on the Inclusion of Environmental Criteria in Public Procurement. This

The State AG Report Weekly Update May 5, 2016
  • Cozen O'Connor
  • USA
  • May 5 2016

The Co-Chairs of the Democratic Attorneys General Association (“DAGA”), Oregon AG Ellen Rosenblum, District of Columbia AG Karl Racine, and Virginia

Eleventh Indonesian economic policy package: improving national competitiveness in the global economic battle
  • ABNR
  • Indonesia
  • May 3 2016

The Indonesian Government unveiled, on Tuesday, 29 March 2016, its 11th economic stimulus package ("Package"). The Package is the latest of the

Drug and Medical Device Corruption Risks in China
  • Volkov Law Group
  • USA, China
  • March 7 2016

Medical device and pharmaceutical companies know the risks of conducting business in China. Company after company has had to settle FCPA enforcement

EMEA healthcare industry group newsletter - November 2015
  • Baker McKenzie
  • Netherlands, Spain, OECD, European Union, France, Hungary, Italy
  • November 20 2015

The European Commission has released a new version (1.17) of its manual on borderline and classification in the Community regulatory framework for

Sales representative fraudulently joined? We think so
  • Reed Smith LLP
  • USA
  • October 24 2013

We have removed more cases to federal court than we can count, and we have argued that local andor non-diverse defendants have been fraudulently

Obligation to indemnify executive accused of criminal conduct
  • Dorsey & Whitney LLP
  • USA
  • June 27 2012

I am the general counsel of a corporation in the medical device industry.

The new economic policy in Massachusetts
  • Day Pitney LLP
  • USA
  • March 20 2012

In August 2010, the Massachusetts Legislature passed and the governor signed into law "An Act Relative to Economic Development Reorganization," Chapter 240 of the Acts of 2010, requiring every administration to develop an economic development policy and strategic plan for the commonwealth.

Recent prison sentences demonstrate increased exposure for corporate officers
  • Holland & Knight LLP
  • USA
  • November 29 2011

Last week, three former executives of a medical device company were sentenced to federal prison terms for their roles in managing a company that marketed a device for an unauthorized use and conducted unauthorized clinical trials that were associated with the deaths of three participants.